Predictive Oncology Inc functions in the healthcare domain. The firm has three operating segments: Domestic, International, and Helomics. Domestic and international consist of STREAMWAY System product sales. The Helomics segment consists of clinical testing and contract research. It is a medical device company that develops and manufactures The STREAMWAY System, a solution for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. The Company distributes these products to hospitals, surgical centers and other medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented and disposed of.